Le Lézard
Classified in: Health
Subject: AWD

INOVAIT awards two leading companies and one academic partner for transforming Canada's healthcare ecosystem


TORONTO, April 25, 2024 /CNW/ - INOVAIT, the national network for commercializing breakthroughs in image-guided therapy (IGT) and artificial intelligence, presented the inaugural INOVAIT awards at its annual Discovery Forum last week (April 18, 2024). The awards were established to recognize INOVAIT members (Industry and Academic) who are developing breakthrough innovations in healthcare and spearheading economic development for Canada.

"The INOVAIT awards grew out of our desire to recognize and spotlight members and institutions doing exceptional things to impact medtech innovation in Canada," said Raphael Ronen, co-executive director of INOVAIT. "Together, the recipients of the 2024 INOVAIT awards showcase Canada's exceptional talent, technology, and impact."

The inaugural 2024 INOVAIT awards were granted to the following recipients:

In addition to the award ceremony, the INOVAIT Discovery Forum featured an impressive lineup of industry experts and healthcare influencers, including remarks from Dr. Greg Sorensen, former CEO of Siemens Healthcare North America and current CEO of DeepHealth. To learn more about the 2024 Discovery Forum, visit https://inovait.ca/news/.

About INOVAIT

Established in 2020, INOVAIT invests strategically in collaborative partnerships that build upon Canada's strength in digital innovation and health science research to create a critical mass of world-leading Image-guided therapy (IGT) companies. Hosted by the Sunnybrook Research Institute and supported by the Government of Canada's Strategic Innovation Fund, the Network brings together small, medium-sized, and large companies, research organizations, post-secondary institutions, and not-for-profit organizations. INOVAIT aims to build an integrated IGT ecosystem by fuelling continuous innovation that revolutionizes healthcare globally.

SOURCE INOVAIT


These press releases may also interest you

at 08:05
GE HealthCare today unveiled SIGNA MAGNUS, an FDA 510(k) pending head-only magnetic resonance (MR) scanner designed to explore advancements in neuroscience, which have been restricted by the performance limitations of conventional whole-body MR...

at 07:00
To mark National Hospice Palliative Care Week, the Quebec Coalition for Palliative Care Access (the Coalition) is proud to celebrate the positive impact of palliative care on the well-being of people with life-limiting illness. Palliative care is...

at 06:00
A native born and trained Brazilian oncologist is in the forefront of a new era in the treatment of cancer patients with cutting edge proton therapy medical technology developed in Israel by P-Cure. "It is my dream to be able to bring the P-Cure...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers, today announced results from a new analysis of the ATLAS trial, which estimates using Kaplan Meier...

4 mai 2024
UroGen Pharma Ltd. , a biotech company dedicated to developing and commercializing novel solutions that treat urothelial and specialty cancers, today highlights the results of a sub-analysis from a real-world patient cohort review of JELMYTO...

4 mai 2024
Women's Heart Health Month is recognized every May and is focused on raising awareness about cardiovascular health among women. It aims to educate women about the risks, symptoms, and prevention of heart disease, which is the leading cause of death...



News published on and distributed by: